TEST.H — FluroTech Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for FluroTech, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.35 | -0.884 | -10.6 | -1.16 | -0.107 |
| Depreciation | |||||
| Non-Cash Items | 0.471 | -0.851 | 7.92 | 0.701 | -0.035 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.038 | -0.293 | 0.138 | 0.11 | -0.008 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -3.66 | -1.98 | -2.41 | -0.197 | -0.15 |
| Capital Expenditures | -0.057 | — | -0.353 | 0 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.893 | 0.837 | -1.42 | -0.041 | 0.075 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.836 | 0.837 | -1.77 | -0.041 | 0.075 |
| Financing Cash Flow Items | -0.026 | 0.007 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.29 | 0.047 | 4.11 | 0 | -0.03 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.54 | -1.1 | -0.066 | -0.238 | -0.105 |